These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21775166)

  • 1. Relationship of glycemia control to lipid and blood pressure lowering and atherosclerosis: the SANDS experience.
    Mete M; Wilson C; Lee ET; Silverman A; Russell M; Stylianou M; Umans JG; Wang W; Howard WJ; Ratner RE; Howard BV; Fleg JL
    J Diabetes Complications; 2011; 25(6):362-7. PubMed ID: 21775166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.
    Howard BV; Roman MJ; Devereux RB; Fleg JL; Galloway JM; Henderson JA; Howard WJ; Lee ET; Mete M; Poolaw B; Ratner RE; Russell M; Silverman A; Stylianou M; Umans JG; Wang W; Weir MR; Weissman NJ; Wilson C; Yeh F; Zhu J
    JAMA; 2008 Apr; 299(14):1678-89. PubMed ID: 18398080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential impacts of blood pressure and lipid lowering on regression of ventricular and arterial mass: the Stop Atherosclerosis in Native Diabetics Trial.
    Roman MJ; Howard BV; Howard WJ; Mete M; Fleg JL; Lee ET; Devereux RB
    Hypertension; 2011 Sep; 58(3):367-71. PubMed ID: 21788602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving lipid targets in adults with type 2 diabetes: the Stop Atherosclerosis in Native Diabetics Study.
    Russell M; Silverman A; Fleg JL; Lee ET; Mete M; Weir M; Wilson C; Yeh F; Howard BV; Howard WM
    J Clin Lipidol; 2010; 4(5):435-43. PubMed ID: 21076630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.
    Fleg JL; Mete M; Howard BV; Umans JG; Roman MJ; Ratner RE; Silverman A; Galloway JM; Henderson JA; Weir MR; Wilson C; Stylianou M; Howard WJ
    J Am Coll Cardiol; 2008 Dec; 52(25):2198-205. PubMed ID: 19095139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS).
    Russell M; Fleg JL; Galloway WJ; Henderson JA; Howard J; Lee ET; Poolaw B; Ratner RE; Roman MJ; Silverman A; Stylianou M; Weir MR; Wilson C; Yeh F; Zhu J; Howard BV
    Am Heart J; 2006 Nov; 152(5):867-75. PubMed ID: 17070147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
    Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) .
    Wilson C; Huang CC; Shara N; Howard BV; Fleg JL; Henderson JA; Howard WJ; Huentelman H; Lee ET; Mete M; Russell M; Galloway JM; Silverman A; Stylianou M; Umans J; Weir MR; Yeh F; Ratner RE
    J Clin Lipidol; 2010; 4(3):165-72. PubMed ID: 20563294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of glycaemic variability and carotid intima-media thickness in patients with type 2 diabetes mellitus].
    Yang XJ; He H; Lü XF; Wen XR; Wang C; Chen DW; Li XJ; Ran XW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):734-8. PubMed ID: 23230750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
    Gutierrez MJ; Rosenberg NL; Macdougall DE; Hanselman JC; Margulies JR; Strange P; Milad MA; McBride SJ; Newton RS
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):676-83. PubMed ID: 24385236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDY.
    Howard WJ; Russell M; Fleg JL; Mete M; Ali T; Devereux RB; Galloway JM; Otvos JD; Ratner RE; Roman MJ; Silverman A; Umans JG; Weissman NJ; Wilson C; Howard BV
    J Clin Lipidol; 2009 Oct; 3(5):322-331. PubMed ID: 20161568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque Hypertension Lipid Lowering Italian Study. PHYLLIS study group.
    Zanchetti A; Crepaldi G; Bond MG; Gallus GV; Veglia F; Ventura A; Mancia G; Baggio G; Sampieri L; Rubba P; Collatina S; Serrotti E
    J Hypertens; 2001 Jan; 19(1):79-88. PubMed ID: 11204308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients.
    Yilmaz R; Altun B; Kahraman S; Ozer N; Akinci D; Turgan C
    Ren Fail; 2010; 32(8):903-12. PubMed ID: 20722555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
    Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial.
    Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R
    Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
    Rump LC; Baranova E; Okopien B; Weisskopf M; Kandra A; Ferber P
    Clin Ther; 2008 Oct; 30(10):1782-93. PubMed ID: 19014834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
    Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial.
    Weir MR; Yeh F; Silverman A; Devereux RB; Galloway JM; Henderson JA; Howard WJ; Russell M; Wilson C; Ratner R; Sorkin J; Umans JG; Fleg JL; Stylianou M; Lee E; Howard BV
    J Clin Hypertens (Greenwich); 2009 Oct; 11(10):540-8. PubMed ID: 19817934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.